- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY
- Oligo State
- homo-hexamer
- Ligands
- 3 x A- A- A: RNA (5'-R(P*AP*AP*AP*AP*AP*A)-3')(Non-covalent)
- 12 x ATP: ADENOSINE-5'-TRIPHOSPHATE(Non-covalent)
ATP.4: 6 residues within 4Å:- Chain A: A.328, F.372, Y.373, E.581, L.582, F.585
5 PLIP interactions:5 interactions with chain A- Hydrogen bonds: A:Y.373, A:Y.373, A:E.581
- pi-Stacking: A:F.585, A:F.585
ATP.5: 7 residues within 4Å:- Chain A: G.247, G.297, N.298, G.301, S.302, N.338, Y.339
6 PLIP interactions:6 interactions with chain A- Hydrogen bonds: A:M.294, A:M.294, A:N.298, A:S.302, A:N.338, A:Y.339
ATP.7: 7 residues within 4Å:- Chain B: R.162, K.165, N.370, F.372, Y.373, F.585, R.588
9 PLIP interactions:9 interactions with chain B- Hydrogen bonds: B:R.162, B:Y.373, B:Y.373, B:R.588, B:R.588
- Salt bridges: B:K.165, B:K.165, B:R.588
- pi-Stacking: B:Y.373
ATP.8: 13 residues within 4Å:- Chain B: G.247, G.248, M.294, G.297, N.298, N.300, G.301, S.302, N.338, Y.339, S.383, A.419, G.420
10 PLIP interactions:10 interactions with chain B- Hydrogen bonds: B:G.247, B:G.297, B:N.300, B:S.302, B:S.302, B:N.338, B:S.383, B:S.383, B:G.420
- pi-Stacking: B:H.245
ATP.10: 3 residues within 4Å:- Chain C: F.372, Y.373, F.585
4 PLIP interactions:4 interactions with chain C- Hydrogen bonds: C:Y.373, C:Y.373
- pi-Stacking: C:F.585, C:F.585
ATP.11: 7 residues within 4Å:- Chain C: H.245, G.247, G.297, N.300, G.301, S.302, N.338
5 PLIP interactions:5 interactions with chain C- Hydrogen bonds: C:H.245, C:G.297, C:S.302, C:S.302, C:N.338
ATP.13: 5 residues within 4Å:- Chain D: K.165, F.372, Y.373, F.585, R.588
6 PLIP interactions:6 interactions with chain D- Hydrogen bonds: D:Y.373, D:Y.373, D:R.588, D:R.588
- Salt bridges: D:K.165, D:R.588
ATP.14: 12 residues within 4Å:- Chain D: G.247, G.248, M.294, G.297, N.298, N.300, G.301, S.302, N.338, S.383, A.419, G.420
8 PLIP interactions:8 interactions with chain D- Hydrogen bonds: D:G.297, D:N.300, D:S.302, D:S.383, D:S.383
- Salt bridges: D:K.303
- pi-Stacking: D:H.245, D:H.245
ATP.16: 6 residues within 4Å:- Chain E: A.328, F.372, Y.373, E.581, L.582, F.585
5 PLIP interactions:5 interactions with chain E- Hydrogen bonds: E:Y.373, E:Y.373, E:E.581
- pi-Stacking: E:F.585, E:F.585
ATP.17: 10 residues within 4Å:- Chain E: G.247, G.248, M.294, G.301, S.302, N.338, Y.339, A.419, H.448, N.534
5 PLIP interactions:5 interactions with chain E- Hydrogen bonds: E:G.247, E:N.338, E:Y.339, E:Y.339, E:H.448
ATP.19: 9 residues within 4Å:- Chain F: D.91, R.162, K.165, N.370, F.372, Y.373, E.581, F.585, R.588
6 PLIP interactions:6 interactions with chain F- Hydrogen bonds: F:D.91, F:Y.373, F:R.588
- Salt bridges: F:R.162, F:K.165, F:R.588
ATP.20: 15 residues within 4Å:- Chain F: G.247, G.248, L.290, M.294, G.297, N.298, N.300, G.301, S.302, N.338, Y.339, I.381, S.383, A.419, G.420
9 PLIP interactions:9 interactions with chain F- Hydrogen bonds: F:G.297, F:G.297, F:S.302, F:N.338, F:Y.339, F:S.383, F:S.383, F:G.420
- pi-Cation interactions: F:H.245
- 6 x MG: MAGNESIUM ION(Non-covalent)
MG.6: 4 residues within 4Å:- Chain A: H.243, H.245, H.448, D.533
4 PLIP interactions:4 interactions with chain A- Metal complexes: A:H.243, A:H.245, A:H.448, A:D.533
MG.9: 4 residues within 4Å:- Chain B: H.243, H.245, H.448, D.533
4 PLIP interactions:4 interactions with chain B- Metal complexes: B:H.243, B:H.245, B:H.448, B:D.533
MG.12: 4 residues within 4Å:- Chain C: H.243, H.245, H.448, D.533
4 PLIP interactions:4 interactions with chain C- Metal complexes: C:H.243, C:H.245, C:H.448, C:D.533
MG.15: 4 residues within 4Å:- Chain D: H.243, H.245, H.448, D.533
4 PLIP interactions:4 interactions with chain D- Metal complexes: D:H.243, D:H.245, D:H.448, D:D.533
MG.18: 4 residues within 4Å:- Chain E: H.243, H.245, H.448, D.533
3 PLIP interactions:3 interactions with chain E- Metal complexes: E:H.243, E:H.245, E:D.533
MG.21: 4 residues within 4Å:- Chain F: H.243, H.245, H.448, D.533
4 PLIP interactions:4 interactions with chain F- Metal complexes: F:H.243, F:H.245, F:H.448, F:D.533
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Baca, C.F. et al., The CRISPR-associated adenosine deaminase Cad1 converts ATP to ITP to provide antiviral immunity. Cell (2024)
- Release Date
- 2024-10-30
- Peptides
- Adenosine deaminase domain-containing protein: ABCDEF
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
CD
DE
EF
F
- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY
- Oligo State
- homo-hexamer
- Ligands
- 3 x A- A- A: RNA (5'-R(P*AP*AP*AP*AP*AP*A)-3')(Non-covalent)
- 12 x ATP: ADENOSINE-5'-TRIPHOSPHATE(Non-covalent)
- 6 x MG: MAGNESIUM ION(Non-covalent)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Baca, C.F. et al., The CRISPR-associated adenosine deaminase Cad1 converts ATP to ITP to provide antiviral immunity. Cell (2024)
- Release Date
- 2024-10-30
- Peptides
- Adenosine deaminase domain-containing protein: ABCDEF
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
CD
DE
EF
F